Cutler Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Cutler Group’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,500	Closed	-$127K	–	6321
2021 Q3	$127K	Sell	2,500 -10,000	-80%	-$319K	0.01%	1725
2021 Q2	$186K	Buy	12,500 +2,500	+25%	+$96.8K	0.01%	1395
2021 Q1	$151K	Buy	10,000 +1,500	+18%	+$69.8K	0.01%	1462
2020 Q4	$83K	Buy	8,500 +1,500	+21%	+$88.9K	﹤0.01%	1663
2020 Q3	$103K	Sell	7,000 -500	-7%	-$24.5K	0.01%	1308
2020 Q2	$87K	Hold	7,500	–	–	0.01%	1396
2020 Q1	$176K	Sell	7,500 -35,900	-83%	-$1.99M	0.01%	1025
2019 Q4	$199K	Buy	+43,400	New	+$2.06M	0.01%	827
2019 Q3	–	Sell	-1,900	Closed	-$6K	–	4847
2019 Q2	$6K	Buy	+1,900	New	+$44.5K	﹤0.01%	3032

Other funds holding DCPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Cutler Group's DCPH Position: Q1 2024 in Review

Cutler Group reduced its Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) stake by 40% in Q1 2024, selling an estimated $3.08K and leaving 300 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1675.

Cutler Group first reported a position in DCPH in Q3 2019 and has held it in 19 quarters since. The position peaked at $1.97M in Q4 2019. 177 funds tracked by Wall St. Rank hold DCPH as of Q1 2024.

Cutler Group held 300 shares of Deciphera Pharmaceuticals, Inc. Common Stock worth $4K as of Q1 2024.
Cutler Group sold 200 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $3.08K.
Deciphera Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1675 holding.
Cutler Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2019 and has held it in 19 quarters since.
Cutler Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.97M in Q4 2019.
177 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.